Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP

Watchlist Manager
Tonix Pharmaceuticals Holding Corp Logo
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Watchlist
Price: 17.09 USD -6.15% Market Closed
Market Cap: 201.3m USD

Wall Street
Price Targets

TNXP Price Targets Summary
Tonix Pharmaceuticals Holding Corp

Wall Street analysts forecast TNXP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNXP is 67.66 USD with a low forecast of 64.64 USD and a high forecast of 73.5 USD.

Lowest
Price Target
64.64 USD
278% Upside
Average
Price Target
67.66 USD
296% Upside
Highest
Price Target
73.5 USD
330% Upside
Tonix Pharmaceuticals Holding Corp Competitors:
Price Targets
BMRN
Biomarin Pharmaceutical Inc
51% Upside
CANTA
Cantargia AB
94% Upside
FDMT
4D Molecular Therapeutics Inc
289% Upside
FHTX
Foghorn Therapeutics Inc.
117% Upside
INCY
Incyte Corp
1% Downside
TNG
Transgene SA
62% Upside
300142
Walvax Biotechnology Co Ltd
36% Downside
ATX
Amplia Therapeutics Ltd
243% Upside

Revenue
Forecast

Revenue Estimate
Tonix Pharmaceuticals Holding Corp

The compound annual growth rate of Tonix Pharmaceuticals Holding Corp's revenue for the next 3 years is 137%.

N/A
Past Growth
137%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Tonix Pharmaceuticals Holding Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Tonix Pharmaceuticals Holding Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNXP's stock price target?
Price Target
67.66 USD

According to Wall Street analysts, the average 1-year price target for TNXP is 67.66 USD with a low forecast of 64.64 USD and a high forecast of 73.5 USD.

What is Tonix Pharmaceuticals Holding Corp's Revenue forecast?
Projected CAGR
137%

The compound annual growth rate of Tonix Pharmaceuticals Holding Corp's revenue for the next 3 years is 137%.

Back to Top